| Lindsay Marie Reeves, FNP-C | |
|
1957 Thompson Rd Ste G, Coos Bay, OR 97420-2040 | |
| (541) 404-6848 | |
| (541) 982-7283 |
| Full Name | Lindsay Marie Reeves |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1957 Thompson Rd Ste G, Coos Bay, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336895556 | NPI | - | NPPES |
| Entity Name | Coquille Indian Tribe |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376592287 PECOS PAC ID: 6002805330 Enrollment ID: O20040511000663 |
News Archive
Nanoengineers at the University of California San Diego have developed immune cell-mimicking nanoparticles that target inflammation in the lungs and deliver drugs directly where they're needed. As a proof of concept, the researchers filled the nanoparticles with the drug dexamethasone and administered them to mice with inflamed lung tissue.
Bound Tree Medical, the nation's leading provider of emergency medical supplies and equipment to the pre-hospital market, today announced that it has acquired Alliance Medical, Inc.
Reuters examines the effort to create an effective malaria vaccine and asks: "[I]s the vaccine - and the global health community's aim of completely eradicating a disease that kills a child every 45 seconds - really worth the money?"
Patients with stable asthma who stop using low-dose inhaled corticosteroids are at a significantly increased risk for exacerbations over the following 6 months, show results from a systematic review and meta-analysis of published studies.
› Verified 3 days ago
| Entity Name | Icco Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407004757 PECOS PAC ID: 1355406729 Enrollment ID: O20090218000510 |
News Archive
Nanoengineers at the University of California San Diego have developed immune cell-mimicking nanoparticles that target inflammation in the lungs and deliver drugs directly where they're needed. As a proof of concept, the researchers filled the nanoparticles with the drug dexamethasone and administered them to mice with inflamed lung tissue.
Bound Tree Medical, the nation's leading provider of emergency medical supplies and equipment to the pre-hospital market, today announced that it has acquired Alliance Medical, Inc.
Reuters examines the effort to create an effective malaria vaccine and asks: "[I]s the vaccine - and the global health community's aim of completely eradicating a disease that kills a child every 45 seconds - really worth the money?"
Patients with stable asthma who stop using low-dose inhaled corticosteroids are at a significantly increased risk for exacerbations over the following 6 months, show results from a systematic review and meta-analysis of published studies.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lindsay Marie Reeves, FNP-C 1957 Thompson Rd Ste G, Coos Bay, OR 97420-2040 Ph: (541) 404-6848 | Lindsay Marie Reeves, FNP-C 1957 Thompson Rd Ste G, Coos Bay, OR 97420-2040 Ph: (541) 404-6848 |
News Archive
Nanoengineers at the University of California San Diego have developed immune cell-mimicking nanoparticles that target inflammation in the lungs and deliver drugs directly where they're needed. As a proof of concept, the researchers filled the nanoparticles with the drug dexamethasone and administered them to mice with inflamed lung tissue.
Bound Tree Medical, the nation's leading provider of emergency medical supplies and equipment to the pre-hospital market, today announced that it has acquired Alliance Medical, Inc.
Reuters examines the effort to create an effective malaria vaccine and asks: "[I]s the vaccine - and the global health community's aim of completely eradicating a disease that kills a child every 45 seconds - really worth the money?"
Patients with stable asthma who stop using low-dose inhaled corticosteroids are at a significantly increased risk for exacerbations over the following 6 months, show results from a systematic review and meta-analysis of published studies.
› Verified 3 days ago